rs121434568
|
|
Non-Small Cell Lung Carcinoma
|
A |
0.800 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs1057519848
|
|
Non-Small Cell Lung Carcinoma
|
GT |
0.800 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs1057519847
|
|
Non-Small Cell Lung Carcinoma
|
AG |
0.800 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs28929495
|
|
Non-Small Cell Lung Carcinoma
|
C |
0.750 |
GeneticVariation
|
CLINVAR |
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
|
15118125 |
2004 |
rs28929495
|
|
Non-Small Cell Lung Carcinoma
|
C |
0.750 |
GeneticVariation
|
CLINVAR |
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
|
15118073 |
2004 |
rs28929495
|
|
Non-Small Cell Lung Carcinoma
|
C |
0.750 |
GeneticVariation
|
CLINVAR |
Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer.
|
15788655 |
2005 |
rs121913465
|
|
Non-Small Cell Lung Carcinoma
|
T |
0.740 |
GeneticVariation
|
CLINVAR |
EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapy.
|
17653080 |
2008 |
rs121913465
|
|
Non-Small Cell Lung Carcinoma
|
T |
0.740 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913465
|
|
Non-Small Cell Lung Carcinoma
|
T |
0.740 |
GeneticVariation
|
CLINVAR |
Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
|
19147750 |
2009 |
rs121913428
|
|
Non-Small Cell Lung Carcinoma
|
A |
0.740 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913428
|
|
Non-Small Cell Lung Carcinoma
|
A |
0.740 |
GeneticVariation
|
CLINVAR |
Erlotinib response in an NSCLC patient with a novel compound G719D+L861R mutation in EGFR.
|
23945392 |
2013 |
rs28929495
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.720 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs149840192
|
|
Glioblastoma
|
A |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs149840192
|
|
Glioblastoma
|
T |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913444
|
|
Adenocarcinoma of lung (disorder)
|
A |
0.710 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs769696078
|
|
Glioblastoma
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs769696078
|
|
Brain Neoplasms
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs769696078
|
|
Squamous cell carcinoma of the head and neck
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs397517116
|
|
Non-Small Cell Lung Carcinoma
|
CCACGTG |
0.700 |
GeneticVariation
|
CLINVAR |
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
|
16533793 |
2006 |
rs397517116
|
|
Non-Small Cell Lung Carcinoma
|
CCACGTG |
0.700 |
GeneticVariation
|
CLINVAR |
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.
|
16187797 |
2005 |
rs397517114
|
|
Non-Small Cell Lung Carcinoma
|
CCCCACG |
0.700 |
GeneticVariation
|
CLINVAR |
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.
|
16187797 |
2005 |
rs397517106
|
|
Non-Small Cell Lung Carcinoma
|
CTCCAGGAAGCCT |
0.700 |
GeneticVariation
|
CLINVAR |
EGFR somatic doublets in lung cancer are frequent and generally arise from a pair of driver mutations uncommonly seen as singlet mutations: one-third of doublets occur at five pairs of amino acids.
|
18372921 |
2008 |
rs397517098
|
|
Non-Small Cell Lung Carcinoma
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
rs397517097
|
|
Carcinoma of lung
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib.
|
16043828 |
2005 |
rs397517097
|
|
Squamous cell carcinoma of lung
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer.
|
22753918 |
2012 |